Language:

First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015–2017

The Canadian journal of infectious diseases & medical microbiology, 2022, Vol.2022, p.4935811-7 [Peer Reviewed Journal]

Copyright © 2022 Kamal Dumaidi et al. ;Copyright © 2022 Kamal Dumaidi et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2022 Kamal Dumaidi et al. 2022 ;ISSN: 1712-9532 ;EISSN: 1918-1493 ;DOI: 10.1155/2022/4935811 ;PMID: 35178134

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015–2017
Author: Dumaidi, Kamal ; Abudamous, Alaa M. ; Abu-Helu, Rasmi ; Al-Jawabreh, Hanan ; Dumaidi, Yazan ; Al-Jawabreh, Amer
Snoussi, Mejdi ; Mejdi Snoussi
Subjects: Age groups ; Asymptomatic ; Blood & organ donations ; Blood transfusions ; Data collection ; Demographics ; Demography ; Females ; Food contamination & poisoning ; Health risks ; Hepatitis ; Immunoglobulin G ; Infections ; Infectious diseases ; Laboratories ; Population ; Risk analysis ; Risk factors ; Sample size ; Seroepidemiology ; Serology ; Socioeconomic factors ; Spatial analysis ; Statistical analysis ; Viruses
Is Part Of: The Canadian journal of infectious diseases & medical microbiology, 2022, Vol.2022, p.4935811-7
Description: Hepatitis E virus is emerging viral hepatitis with hyperendemicity in many countries. Data on the burden of disease is not available in Palestine. This study aims to determine the seroprevalence and the risk factors of the HEV among the general population of the West Bank, Palestine. In this cross-sectional study, a total of 432 sera samples from 40 localities in the eleven districts of the West Bank and Jerusalem, Palestine, during the period of March 2015 to March 2017, were tested for HEV-IgG. A structured questionnaire was used to collect data of the participants’ demographics and disease risk factors. The overall seroprevalence was 3.7%. Level of education was significantly inversely associated with HEV seropositivity (P=0.04). Purely spatial analysis did not detect any significant cluster related to the distribution of HEV-IgG cases; however, living in the southern West Bank is shown to be significantly associated with HEV. Age was also associated with HEV seropositivity. The young (<19 years) and adults (>40 years) had the highest prevalence, compared to those between 20 to 39 years old (P=0.12). Furthermore, males and those in contact with animals were associated with HEV seropositivity (P=0.1 and 0.3, respectively). In conclusion, the seroprevalence of HEV IgG in the West Bank, Palestine is low. Several well-investigated risk factors cannot be supported by our results due to the small number of the positive HEV-IgG samples. Finally, this study is useful for providing a first look into the seroepidemiology of HEV in Palestine.
Publisher: Egypt: Hindawi
Language: English;French
Identifier: ISSN: 1712-9532
EISSN: 1918-1493
DOI: 10.1155/2022/4935811
PMID: 35178134
Source: GFMER Free Medical Journals
PubMed Central
ProQuest Central
DOAJ Directory of Open Access Journals

Back to results list